key: cord-0923462-31vt50pk authors: Mallet, Vincent; Schwarzinger, Michaƫl title: Reply Prognosis of Covid-19 patients with chronic liver disease in France in 2020 date: 2021-10-02 journal: J Hepatol DOI: 10.1016/j.jhep.2021.09.022 sha: 8b63e67c11f2a1a825aef2882ffa74b47301d0b5 doc_id: 923462 cord_uid: 31vt50pk nan Financial support The study did not receive any external funding Contributorship statement VM, MS: conception of the study, analysis and interpretation of the data, draft of the manuscript. All other members of the Demosthenes group facilitated the study or took care of the reported patients. We are not sure what the correspondents meant by "selection criteria to conduct multivariate analyzed", but no selection procedure was applied among covariates in the multivariate regression analysis given the large sample size. In addition, issues of multicollinearity, a concern for our correspondents, were unlikely given the large sample size: the median variance inflation factor was Factors associated with COVID-19-related death using OpenSAFELY High rates of 30-day mortality in patients with cirrhosis and COVID-19 Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study Generalized Collinearity Diagnostics